HI
EW icon

Handelsinvest Investeringsforvaltning’s Edwards Lifesciences EW Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-27,049
Closed -$1.87M – 339
2023
Q3 		$1.87M Sell
27,049
-276
-1% -$22.2K 0.65% 74
2023
Q2 		$2.58M Buy
+27,325
New +$2.37M 0.51% 59

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Handelsinvest Investeringsforvaltning's EW Position: Q4 2023 in Review

Handelsinvest Investeringsforvaltning sold out of Edwards Lifesciences (EW) in Q4 2023, closing a stake of 27,049 shares — an estimated $1.87M sold.

Handelsinvest Investeringsforvaltning first reported a position in EW in Q2 2023 and held it in 2 quarters. The position peaked at $2.58M in Q2 2023. 1,245 funds tracked by Wall St. Rank hold EW as of Q4 2023.

  • Handelsinvest Investeringsforvaltning reported no remaining Edwards Lifesciences position as of Q4 2023 after selling out during the quarter.
  • Handelsinvest Investeringsforvaltning sold 27,049 Edwards Lifesciences shares in Q4 2023, an estimated $1.87M.
  • Handelsinvest Investeringsforvaltning first reported a position in Edwards Lifesciences in Q2 2023 and held it in 2 quarters.
  • Handelsinvest Investeringsforvaltning's Edwards Lifesciences position peaked at $2.58M in Q2 2023.
  • 1,245 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2023.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q4 2023, filed 11 Jan 2024.